524156 — TCM Income Statement
0.000.00%
Last trade - 00:00
- IN₹406.57m
- IN₹393.70m
- IN₹73.48m
2019 March 31st | 2020 March 30th | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | Interim Report | ARS |
Standards: | IAS | IAS | IAS | — | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.96 | 9.2 | 42.5 | 35.5 | 73.5 |
Cost of Revenue | |||||
Gross Profit | -0.264 | 2.68 | 23.7 | 9.49 | 15.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.9 | 17.6 | 51.8 | 103 | 114 |
Operating Profit | -9.9 | -8.44 | -9.27 | -67.6 | -40.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.48 | 3.05 | 3.07 | -58.8 | -43 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.48 | 3.05 | 1.18 | -58.8 | -42.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -9.48 | 3.05 | 1.18 | -51.4 | -40 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.48 | 3.05 | 1.18 | -51.4 | -40 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.79 | 0.897 | 0.348 | -6.35 | -5.97 |